Old Web
English
Sign In
Acemap
>
authorDetail
>
Jill Suzanne Whyte
Jill Suzanne Whyte
North Shore University Hospital
Medicine
Ovarian cancer
Pathology
Cohort
Atypical Endometrial Hyperplasia
3
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy outcomes for patients ages 65 and older treated with dose-dense chemotherapy for epithelial ovarian cancer.
2017
Journal of Clinical Oncology
Eleonora Teplinsky
Haven Lindsay Caldwell
Nina Kohn
Kit Cheng
Mark Hoffman
Lisa A. Dos Santos
Antoinette Sakaris
Karin Shih
John L. Lovecchio
Jill Suzanne Whyte
Andrew Menzin
V. John
Show All
Source
Cite
Save
Citations (0)
Association of MiR-26b mediated doxorubicin resistance signature with poor prognosis in epithelial ovarian cancer (EOC).
2016
Journal of Clinical Oncology
Ilya Korsunsky
Janaki Parameswaran
Iuliana Shapira
Michaela Oswald
John L. Lovecchio
Andrew Menzin
Jill Suzanne Whyte
Lisa A. Dos Santos
Sharon X. Liang
Tawfiqul Bhuiya
Mary Keogh
C Mason
Houman Khalili
Meagan Fastuca
Cassandra Pond
Anthony Liew
Peter K. Gregersen
Annette Lee
Show All
Source
Cite
Save
Citations (0)
Lymph node dissection in the surgical management of atypical endometrial hyperplasia.
2010
American Journal of Obstetrics and Gynecology
Jill Suzanne Whyte
Elizabeth P. Gurney
John P. Curtin
Stephanie V. Blank
Show All
Source
Cite
Save
Citations (15)
1